Literature DB >> 33581655

Carfentanil - from an animal anesthetic to a deadly illicit drug.

Jolanta B Zawilska1, Katarzyna Kuczyńska2, Wiktoria Kosmal2, Katarzyna Markiewicz2, Piotr Adamowicz3.   

Abstract

The use of novel synthetic opioids as recreational drugs has become a public health concern as they are implicated in numerous fatal intoxications across the world. Synthetic opioids have played a major role in the United States opioid crisis and may contribute to a similar opioid epidemic in Europe. The most prominent group of designer opioids consists of fentanyl and its analogues. At present, carfentanil is the most dangerous fentanyl derivative. It was recently detected as an adulterant to other illicit drugs and counterfeit pharmaceuticals, contributing to life-threatening hospital admissions and fatalities. Toxic exposure to carfentanil typically occurs through injection, insufflation or inhalation. Carfentanil produces similar pharmacotoxicological effects to other opioids. However, due to its extraordinary potency, reversing carfentanil-induced severe and recurring respiratory depression requires administration of multiple or higher than standard doses of naloxone. Toxicological reports indicate that carfentanil use is strongly connected to polydrug use. Detection of carfentanil requires specific and sensitive analytical methods that are not commonly available in hospitals. Since abuse of carfentanil is an emerging problem, particularly in the United States, there is an urgent need to develop new techniques for rapid determination of intoxication evoked by this drug as well as new treatment regimens for effective overdose maintenance. This review presents current knowledge on pharmacological activity of carfentanil, prevalence and patterns of use, and analytical methods of its detection. Special emphasis is given to carfentanil-related non-fatal and lethal overdose cases.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carfentanil; New psychoactive substances; Synthetic opioids; Toxicity

Mesh:

Substances:

Year:  2021        PMID: 33581655     DOI: 10.1016/j.forsciint.2021.110715

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

Review 1.  Blood concentrations of new synthetic opioids.

Authors:  Piotr Adamowicz; Karolina Nowak
Journal:  Int J Legal Med       Date:  2021-10-22       Impact factor: 2.686

2.  A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor.

Authors:  Bing Xie; Alexander Goldberg; Lei Shi
Journal:  Comput Struct Biotechnol J       Date:  2022-05-14       Impact factor: 6.155

3.  Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment.

Authors:  Michael Specka; Thomas Kuhlmann; Udo Bonnet; Jürgen Sawazki; Luzia Schaaf; Stefan Kühnhold; Renate Steinert; Torsten Grigoleit; Helmut Eich; Benita Zeiske; Antje Niedersteberg; Katharina Steiner; Fabrizio Schifano; Norbert Scherbaum
Journal:  Front Psychiatry       Date:  2022-06-01       Impact factor: 5.435

Review 4.  Electroanalysis of Fentanyl and Its New Analogs: A Review.

Authors:  Marta Katarzyna Choińska; Ivana Šestáková; Vojtěch Hrdlička; Jana Skopalová; Jan Langmaier; Vítězslav Maier; Tomáš Navrátil
Journal:  Biosensors (Basel)       Date:  2022-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.